World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 2 May 2022
Main ID:  NCT03488290
Date of registration: 28/03/2018
Prospective Registration: Yes
Primary sponsor: Pakistan Institute of Living and Learning
Public title: Building Resilience Against ViolencE (BRAVE) BRAVE
Scientific title: Building Resilience Against ViolencE (BRAVE): A Parenting Intervention for Mothers and Fathers With Post-traumatic Stress Symptoms.
Date of first enrolment: April 20, 2018
Target sample size: 300
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03488290
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Pakistan
Contacts
Name:     Nasim Chaudhry
Address: 
Telephone:
Email:
Affiliation:  Pakistan Institute of Living & Learning
Key inclusion & exclusion criteria

Inclusion Criteria:

Participants will be included in the study if they are:

Parents over the age of 16 years who are living with their children age 3-6 years. They
meet the criteria for Post-Traumatic Stress Disorder (PTSD) and are able to give informed
consent

Exclusion Criteria:

Participants will be excluded from the study if they have:

Any diagnosed physical or learning disability which prevents them from attending the LTP+
group intervention, or suffering from psychosis or those who are actively suicidal. This
will be assessed by the research team at screening stage. Any disabilities or diagnosed
mental illness. Any parent who is on current use of anti-depressant medication. And a prior
self-reported mental illness, including depression.



Age minimum: 16 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Post Traumatic Stress Disorder
Intervention(s)
Behavioral: LTP Plus TF-CBT
Other: Treatment as Usual
Primary Outcome(s)
Clinically administered PTSD Scale-5 (CAPS-5) [Time Frame: Changes from Baseline to 4th Month]
Secondary Outcome(s)
Generalized Anxiety Disorder (GAD) 7 [Time Frame: Changes from Baseline to 4th Month]
Patient Health Questionnaire (PHQ-9) [Time Frame: Changes from Baseline to 4th Month]
Ages and Stages Questionnaire [Time Frame: Changes from Baseline to 4th Month]
Client Service Receipt Inventory (CSRI) [Time Frame: Changes from Baseline to 4th Month]
Secondary ID(s)
PILL-BRAVE01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history